The<i>BIRC6</i>gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis
Sze Ue Luk(Vancouver General Hospital), Yuzhuo Wang(BC Cancer Agency)
Cited by 33
Related Papers
Patient-Derived First Generation Xenografts of Non–Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy
|Clinical Cancer Research|2010|195
The x c − cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine
|Cancer Chemotherapy and Pharmacology|2008|131
An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line
|Laboratory Investigation|2005|111
Establishment in Severe Combined Immunodeficiency Mice of Subrenal Capsule Xenografts and Transplantable Tumor Lines from a Variety of Primary Human Lung Cancers: Potential Models for Studying Tumor Progression–Related Changes
|Clinical Cancer Research|2006|107
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer
|European Urology|2020|90